Clemastine alleviates cognitive dysfunction after SAH by targeting neuronal CNTN1 to regulate the ADA-adenosine pathway. Li L-X, Wei B-Y, Jin L, Wu Y, Yang Z-Y, Li C, Zhou J-M, Song Y, Gong W-Z, Ou-Yang Y-H, et al. Acta Pharmacol Sin. 2026 Jun 23. PMID: 42337055. Abstract CommentRecommendBookmarkWatch
